This service is more advanced with JavaScript available, learn more at http://activatejavascript.org

Advertisement

Reactions Weekly

March 2018, Volume 1695, Issue 1, pp 288–288 | Cite as

Ombitasvir/paritaprevir/ritonavir

Fatal liver failure, hepatic encephalopathy and variceal bleeding: 3 case reports

Case report

First Online: 31 March 2018

14 Downloads

This is a preview of subscription content, to check access.

Reference

Perello C, et al. Effectiveness and safety of ombitasvir, paritaprevir, ritonavir +/- dasabuvir +/- ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection. Journal of Viral Hepatitis 24: 226-237, No. 3, Mar 2017. Available from: URL: http://doi.org/10.1111/jvh.12637 - SpainCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

About this article

Cite this article as:: Reactions Weekly (2018) 1695: 288. https://doi.org/10.1007/s40278-018-44115-1

DOI https://doi.org/10.1007/s40278-018-44115-1
Publisher Name Springer International Publishing
Print ISSN 0114-9954
Online ISSN 1179-2051

Published in cooperation with
Adis

Personalised recommendations

Unlimited access to the full article
Instant download
Include local sales tax if applicable

Rent this article via DeepDyve

Cite article

Advertisement